Circulating irisin detection: Does it really work?

Trends in Endocrinology and Metabolism

Volumn 26, Issue 7, 2015, Pages 335-336

  Sanchis Gomar, Fabian ^a   Alis, Rafael ^b   Lippi, Giuseppe ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^c ACADEMIC HOSPITAL OF PARMA   (Italy)

Author keywords

Antibodies; ELISA kit; Exercise; FNDC5; Irisin; Mass spectrometry

Indexed keywords

IRISIN; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ANALYTIC METHOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE DETERMINATION; HUMAN; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DENATURATION; SHORT SURVEY; WESTERN BLOTTING;

FIBRONECTINS; HUMANS; MASS SPECTROMETRY;

EID: 84937519810     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.05.004     Document Type: Short Survey

References (12)

1. Servick K. Biomedicine. Woes for 'exercise hormone'. Science (New York, N.Y.) 2015, 347:1299.
2. Bostrom P., et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
3. Sanchis-Gomar F., et al. Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. J. Diabetes 2012, 4:196.
4. Sanchis-Gomar F., Perez-Quilis C. Irisinemia: A novel concept to coin in clinical medicine?. Ann. Nutr. Metab. 2013, 63:60-61.
5. Sanchis-Gomar F., et al. Inconsistency in circulating irisin levels: what is really happening?. Horm. Metab. Res. 2014, 46:591-596.
6. Elsen M., et al. Browning of white fat: does irisin play a role in humans?. J. Endocrinol. 2014, 222:R25-R38.
7. Erickson H.P. Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor?. Adipocyte 2013, 2:289-293.
8. Timmons J.A., et al. Is irisin a human exercise gene?. Nature 2012, 488. E9-10.
9. Lee P., et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014, 19:302-309.
10. Albrecht E., et al. Irisin - a myth rather than an exercise-inducible myokine. Sci. Rep. 2015, 5:8889.
11. Lippi G., et al. Prostate-specific antigen-based screening for prostate cancer in the third millennium: useful or hype?. Ann. Med. 2009, 41:480-489.
12. Irving B.A., et al. Does IRISIN Have a BRITE future as a therapeutic agent in humans?. Curr. Obes. Rep. 2014, 3:235-241.